|Bid||15.74 x 800|
|Ask||15.76 x 900|
|Day's Range||14.16 - 15.80|
|52 Week Range||5.85 - 24.30|
|Beta (5Y Monthly)||2.12|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 05, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.33|
The latest analyst coverage could presage a bad day for Ocular Therapeutix, Inc. ( NASDAQ:OCUL ), with the analysts...
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported financial results for the first quarter of 2021, and provided updates on its strong ophthalmology pipeline.
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Ocular Therapeutix, Inc. (NASDAQ:OCUL) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.